Ezetimibe indication widened
In Clinical
Follow this topic
Bookmark
Record learning outcomes
The MHRA recently extended the indication for ezetimibe (Ezetrol) to include reducing the risk of CV events in patients with CHD and a history of acute coronary syndrome. Ezetimibe should be added to, or initiated with, a statin.